Food/Recall·openFDA/food

LIQUID BLENZ CORP — Class II: Menopause Bully 16 oz and 32 oz.

HighPublished May 27, 2026· AI-analyzed Jun 1, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

LIQUID BLENZ CORP has initiated a Class II recall for its 'Menopause Bully' product in 16 oz and 32 oz sizes due to potential under-processing and the presence of unauthorized health claims. The processing deficiency could lead to the growth of Clostridium botulinum.

Who it affects

This recall impacts LIQUID BLENZ CORP, food safety and quality assurance teams in the beverage sector, and distributors or retailers handling the 'Menopause Bully' product lines.

Why it matters

The mention of Clostridium botulinum suggests a significant breakdown in thermal processing or acidification controls, which poses a severe biological hazard. The source also notes 'health claims' as a factor, which suggests that regulatory scrutiny may be amplified when products marketed with therapeutic intent fail to meet basic sanitation and processing standards. This dual failure—safety and labeling—is a critical indicator of systemic quality management system (QMS) deficiencies.

Practical takeaway

Verify thermal processing validation data for products with health claims; perform immediate inventory reconciliation for the specified product sizes; review labeling for unapproved health claims that may invite heightened regulatory scrutiny during safety investigations.

FDA source material

Class II. Reason: May be under-processed resulting in growth of Clostridium botulinum and lists health claims.. Product: Menopause Bully 16 oz and 32 oz.. Firm: LIQUID BLENZ CORP (Rockville Centre NY United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.